Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Reiter

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
International Journal of Cancer|July 1, 1994
Cytotoxic and antitumor activity of a recombinant immunotoxin composed of disulfide-stabilized anti-Tac Fv fragment and truncated Pseudomonas exotoxinY Reiter, R J Kreitman, U Brinkmann, et al.
Journal of Molecular Biology|July 9, 1999
An antibody single-domain phage display library of a native heavy chain variable region: isolation of functional single-domain VH molecules with a unique interfaceY Reiter, P Schuck, L F Boyd, et al.
International Journal of Cancer|July 28, 1995
Administration of disulfide-stabilized Fv-immunotoxins B1(dsFv)-PE38 and B3(dsFv)-PE38 by continuous infusion increases their efficacy in curing large tumor xenografts in nude miceI Benhar, Y Reiter, L H Pai, et al.
International Journal of Cancer|July 3, 1996
Recombinant single-chain and disulfide-stabilized Fv-immunotoxins that cause complete regression of a human colon cancer xenograft in nude miceY Reiter, A F Wright, D W Tonge, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1990
Potentiation of NK cytotoxicity by antibody-C3b/iC3b heteroconjugatesE Yefenof, R Benizri, Y Reiter, et al.
Molecular Immunology|March 1, 1995
Preparation and characterization of a disulfide-stabilized Fv fragment of the anti-Tac antibody: comparison with its single-chain analogK O Webber, Y Reiter, U Brinkmann, et al.
International Journal of Cancer|December 18, 2001
Targeting multidrug resistant tumor cells with a recombinant single-chain FV fragment directed to P-glycoproteinR Niv, Y G Assaraf, D Segal, et al.
Current Pharmaceutical Biotechnology|August 3, 2001
Antibody engineering for targeted therapy of cancer: recombinant Fv-immunotoxinsR Niv, C J Cohen, G Denkberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1995
Complement membrane attack complex, perforin, and bacterial exotoxins induce in K562 cells calcium-dependent cross-protection from lysisY Reiter, A Ciobotariu, J Jones, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1993
A recombinant immunotoxin containing a disulfide-stabilized Fv fragmentU Brinkmann, Y Reiter, S H Jung, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
International Journal of Cancer|July 1, 1994
Cytotoxic and antitumor activity of a recombinant immunotoxin composed of disulfide-stabilized anti-Tac Fv fragment and truncated Pseudomonas exotoxinY Reiter, R J Kreitman, U Brinkmann, et al.
Journal of Molecular Biology|July 9, 1999
An antibody single-domain phage display library of a native heavy chain variable region: isolation of functional single-domain VH molecules with a unique interfaceY Reiter, P Schuck, L F Boyd, et al.
International Journal of Cancer|July 28, 1995
Administration of disulfide-stabilized Fv-immunotoxins B1(dsFv)-PE38 and B3(dsFv)-PE38 by continuous infusion increases their efficacy in curing large tumor xenografts in nude miceI Benhar, Y Reiter, L H Pai, et al.
International Journal of Cancer|July 3, 1996
Recombinant single-chain and disulfide-stabilized Fv-immunotoxins that cause complete regression of a human colon cancer xenograft in nude miceY Reiter, A F Wright, D W Tonge, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1990
Potentiation of NK cytotoxicity by antibody-C3b/iC3b heteroconjugatesE Yefenof, R Benizri, Y Reiter, et al.
Molecular Immunology|March 1, 1995
Preparation and characterization of a disulfide-stabilized Fv fragment of the anti-Tac antibody: comparison with its single-chain analogK O Webber, Y Reiter, U Brinkmann, et al.
International Journal of Cancer|December 18, 2001
Targeting multidrug resistant tumor cells with a recombinant single-chain FV fragment directed to P-glycoproteinR Niv, Y G Assaraf, D Segal, et al.
Current Pharmaceutical Biotechnology|August 3, 2001
Antibody engineering for targeted therapy of cancer: recombinant Fv-immunotoxinsR Niv, C J Cohen, G Denkberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1995
Complement membrane attack complex, perforin, and bacterial exotoxins induce in K562 cells calcium-dependent cross-protection from lysisY Reiter, A Ciobotariu, J Jones, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1993
A recombinant immunotoxin containing a disulfide-stabilized Fv fragmentU Brinkmann, Y Reiter, S H Jung, et al.
Pageof 4